Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hospital days in clozapine-treated patients

R A Dickson1, J T Dalby, R Williams

  • 1University of Calgary, Alberta.

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|November 24, 1998
PubMed
Summary

Continuous clozapine treatment significantly reduces hospital days for patients with treatment-resistant schizophrenia over three years. Interrupting or discontinuing clozapine may negate these benefits and increase risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standards of care in cauda equina syndrome.

British journal of neurosurgery·2016
Same author

Chemical constituents from Gouania longipetala and Glyphaea brevis.

Natural product research·2014
Same author

Tumor prostheses for bone and joint reconstruction.

Orthopedics·2014
Same author

Proceedings of the tenth open scientific meeting of the hip society 1982.

Orthopedics·2014
Same author

Recent advances in orthopaedics.

Orthopedics·2014
Same author

Antibacterial, anti-inflammatory, and antioxidant effects of the leaves and stem bark of Glyphaea brevis (Spreng) Monachino (Tiliaceae): A comparative study.

Pharmacognosy research·2011

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Treatment-resistant schizophrenia poses significant challenges in patient management.
  • Clozapine is an effective but often last-resort medication for schizophrenia.

Purpose of the Study:

  • To evaluate the impact of continuous versus interrupted clozapine treatment on inpatient hospital days.
  • To assess the long-term outcomes of clozapine use in treatment-resistant schizophrenia.

Main Methods:

  • Retrospective chart review of 26 patients over a 6-year period.
  • Analysis of inpatient hospital days before and after clozapine initiation.
  • Categorization of patients based on clozapine treatment adherence (continuous, interrupted, discontinued).

Main Results:

  • Continuous clozapine use for 3 years significantly reduced inpatient days.
  • Patients who interrupted or discontinued clozapine did not show a sustained reduction in hospital days.
  • Three patients who discontinued clozapine died post-treatment, including two suicides.

Conclusions:

  • Sustained, uninterrupted clozapine treatment is crucial for reducing hospitalizations in treatment-resistant schizophrenia.
  • Treatment interruption may lead to loss of therapeutic benefits and increased mortality risk.
  • Development of alternative strategies for patients who do not respond to or discontinue clozapine is urgently needed.

Related Experiment Videos